🔎 Trials Near Me

Pradžia › Antsvoris › Florida › Orlando

Antsvoris klinikiniai tyrimai Orlando, FL

27 tyrimai dėl Antsvoris ieško dalyvių vietose Orlando ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Renkami dalyviai2 fazė
  • Charter Research - Winter Park /ID# 281968, Orlando
  • Florida Institute For Clinical Research /ID# 282739, Orlando
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07752979

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Renkami dalyviai
  • Orlando Health, Inc., Orlando
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07090005

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Renkami dalyviai1 fazėLaukiami sveiki savanoriai
  • Kailera Clinical Site, Orlando
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07793929

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Renkami dalyviai3 fazė
  • Florida Institute for Clinical Research, LLC, Orlando
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Renkami dalyviai2 fazė
  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park · už 5 mylių
  • K2 Medical Research Maitland LLC, Main Office, Maitland · už 6 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Renkami dalyviai2 fazė
  • Clinical Neuroscience Solutions, Orlando
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Renkami dalyviai3 fazė
  • Clinical Neuroscience Solution, Orlando
  • Florida Institute for Clinical Research, LLC, Orlando
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Renkami dalyviai3 fazė
  • Florida Inst For Clin Res LLC, Orlando
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Renkami dalyviai3 fazė
  • Headlands Research Orlando, Orlando
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Renkami dalyviai3 fazė
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Renkami dalyviai3 fazė
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Renkami dalyviai3 fazė
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Renkami dalyviai3 fazė
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · už 5 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Renkami dalyviai3 fazė
  • Research Site, Ocoee · už 10 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Renkami dalyviai3 fazė
  • West Orange Endocrinology, Ocoee · už 10 mylių
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Renkami dalyviai3 fazė
  • Conquest Research, Winter Park · už 5 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Renkami dalyviai2 fazė
  • Charter Research - Winter Park, Orlando
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Renkami dalyviai3 fazė
  • AURORA-1 Clinical Site, Winter Park · už 5 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Renkami dalyviai3 fazė
  • AURORA-2 Clinical Site, Winter Park · už 5 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

Renkami dalyviai
  • University of Central Florida, Orlando
Amžius nuo 5 iki 11 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Renkami dalyviai3 fazėLaukiami sveiki savanoriai
  • ACCOMPLISH-2 Research Site, Ocoee · už 10 mylių
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Renkami dalyviai2 fazė
  • Charter Research - Winter Park, Orlando
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Renkami dalyviai3 fazė
  • Kailera Clinical Site, Orlando
  • Kailera Clinical Site, Orlando
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Renkami dalyviai3 fazė
  • Clinical Neuroscience Solutions - Orlando, Orlando
  • Combined Research Orlando Phase I IV, Orlando
  • Florida Institute for Clinical Research, Orlando
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Renkami dalyviai3 fazė
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · už 5 mylių
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Renkami dalyviai3 fazė
  • Clinical Neuroscience Solutions, Orlando
  • Florida Institute for Clinical Research, Orlando
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-27 · NCT07575399

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Renkami dalyviai3 fazė
  • ACCOMPLISH-1 Research Site, Ocoee · už 10 mylių
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07654361

Antsvoris tyrimai kituose miestuose

Kiti tyrimai Orlando

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.